Early-Phase Clinical Trials
In early-phase trials, precision and expertise are essential to evaluate safety, dosage, and initial efficacy. OWL Oncology Research partners with sponsors to streamline study design, patient recruitment, and data collection, ensuring trials are conducted with efficiency and accuracy. Our team provides strategic oversight while integrating seamlessly with internal teams to optimize trial outcomes. With a strong reputation in oncology research, we help sponsors navigate the complexities of early-stage development, laying the foundation for successful future phases.
Late Phase Trials
Late-phase trials validate the long-term effectiveness and safety of oncology treatments. OWL Oncology Research brings operational excellence to these large-scale studies, ensuring efficient site coordination, comprehensive data analysis, and compliance with global regulatory standards. OWLs can also keep a watchful eye on CROs entrusted with critical and pivotal late stage trials. We provide global QC oversight and co-monitoring services to ensure your vendor is delivering the results you expect, and ensure your sponsor oversight requirements are being met.
Other Trials
Beyond traditional Phase I-III studies, OWL has supported a wide range of trial types, including Observational/Registry Trials, Investigator-Initiated Trials, and Post-Marketing Trials. With expertise spanning every corner of the industry, our network is equipped to handle nearly any request with precision and efficiency.
Examples of Trials We Service
Oncology Trials
-
Phase I / First in Human
-
CAR-T
-
Tumor Infiltrating Lymphocyte
-
Gene Therapy
-
Natural Killer Cell Therapy
-
Bone Marrow Transplant
-
Kinase Inhibitors / Degraders
-
Monoclonal Antibodies
-
Antibody-Drug Conjugates
-
Radiopharmaceuticals
-
Immunostimulants
Non-oncology Trials
-
Rare / Orphan Disease
-
Autoimmune Diseases
-
Diabetes
-
Rheumatology
-
Pain Management
-
Obesity
-
Diagnostics
-
Medical Device
-
General Medicine
-
Transplant Rejection
-
​Many more!